is Director Regulatory Affairs at Symbio Proinnovera. He has extensive expertise in scientific and regulatory affairs, which he acquired in various senior positions in the industry. He specialises in the strategic planning, submission and monitoring of clinical trials for medicinal products and medical devices. This includes the continuous adaptation of applications to new regulatory requirements as well as the comprehensive monitoring and implementation of legal changes through to the preparation of final reports.
Prior to his current role, Dr. Pfaff was Head of Scientific and Regulatory Affairs at Symbio Europe (SRE GmbH) and previously held several key positions at Proinnovera GmbH, including Regulatory Affairs Manager and Lead Clinical Research Associate. He began his academic career by studying biology at the Johann Wolfgang Goethe University in Frankfurt am Main, which he completed with a doctorate in human genetics.
He has been a member of the German Society for Regulatory Affairs (DGRA) since 2017 and actively contributes to the further development of the regulatory environment in Germany.